In advanced pancreatic cancer, the TGF-β pathway is abnormally activated [74], causing quiescent fibroblasts to transform into CAFs that express α-SMA and inhibit the cytotoxic activity of T cells [75, 76]. Here, TGFB1 is linked to familial pancreatic carcinoma.